LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3542 | 4513 | 0.7849 | 0.7038 |
MDA-MB-231 | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4253 | 4513 | 0.9424 | 0.9207 |
MDA-MB-231 | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4088 | 4513 | 0.9058 | 0.8702 |
MDA-MB-231 | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4667 | 4513 | 1.0340 | 1.0468 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3787 | 4513 | 0.8390 | 0.7783 |
MDA-MB-231 | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 1235 | 756 | 4513 | 0.1676 | -0.1462 |
MDA-MB-231 | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 1235 | 692 | 4513 | 0.1533 | -0.1660 |
MDA-MB-231 | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3881 | 4513 | 0.8600 | 0.8072 |
MDA-MB-231 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3537 | 4513 | 0.7838 | 0.7022 |
MDA-MB-231 | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4298 | 4513 | 0.9524 | 0.9344 |
MDA-MB-231 | Nintedanib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4411 | 4513 | 0.9773 | 0.9687 |
MDA-MB-231 | NU7441 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4558 | 4513 | 1.0100 | 1.0137 |
MDA-MB-231 | Dactolisib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1191 | 4513 | 0.2640 | -0.0135 |
MDA-MB-231 | NVP-TAE684 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2913 | 4513 | 0.6455 | 0.5118 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2272 | 4513 | 0.5035 | 0.3163 |
MDA-MB-231 | PD0325901 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1847 | 4513 | 0.4094 | 0.1866 |
MDA-MB-231 | PD0325901 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1800 | 4513 | 0.3988 | 0.1721 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 5078 | 4513 | 1.1252 | 1.1724 |
MDA-MB-231 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3778 | 4513 | 0.8370 | 0.7756 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4219 | 4513 | 0.9349 | 0.9103 |
MDA-MB-231 | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1914 | 4513 | 0.4242 | 0.2071 |
MDA-MB-231 | PF477736 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3065 | 4513 | 0.6791 | 0.5580 |
MDA-MB-231 | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3116 | 4513 | 0.6905 | 0.5738 |
MDA-MB-231 | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4719 | 4513 | 1.0456 | 1.0628 |
MDA-MB-231 | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1167 | 4513 | 0.2586 | -0.0209 |